Search Results - "Madar, Shalom"

Refine Results
  1. 1

    ‘Cancer associated fibroblasts’ – more than meets the eye by Madar, Shalom, Goldstein, Ido, Rotter, Varda

    Published in Trends in molecular medicine (01-08-2013)
    “…Highlights • ‘CAF’ should be conceived as cell ‘state’ rather than a cell type. • Personalized therapy could be extended to the tumor microenvironment…”
    Get full text
    Journal Article
  2. 2

    TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model by Leshem, Orit, Madar, Shalom, Kogan-Sakin, Ira, Kamer, Iris, Goldstein, Ido, Brosh, Ran, Cohen, Yehudit, Jacob-Hirsch, Jasmine, Ehrlich, Marcelo, Ben-Sasson, Shmuel, Goldfinger, Naomi, Loewenthal, Ron, Gazit, Ephraim, Rotter, Varda, Berger, Raanan

    Published in PloS one (01-07-2011)
    “…Prostate cancer is the most common non-dermatologic malignancy in men in the Western world. Recently, a frequent chromosomal aberration fusing androgen…”
    Get full text
    Journal Article
  3. 3

    Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer by Paland, Nicole, Kamer, Iris, Kogan-Sakin, Ira, Madar, Shalom, Goldfinger, Naomi, Rotter, Varda

    Published in Molecular cancer research (01-08-2009)
    “…The prostate is composed of a number of different cell populations. The interaction between them is crucial for the development and proper function of the…”
    Get full text
    Journal Article
  4. 4

    Modulated expression of WFDC1 during carcinogenesis and cellular senescence by Madar, Shalom, Brosh, Ran, Buganim, Yosef, Ezra, Osnat, Goldstein, Ido, Solomon, Hilla, Kogan, Ira, Goldfinger, Naomi, Klocker, Helmut, Rotter, Varda

    Published in Carcinogenesis (New York) (01-01-2009)
    “…Fibroblasts located adjacent to the tumor [cancer-associated fibroblasts (CAFs)] that constitute a large proportion of the cancer-associated stroma facilitate…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta by Madar, Shalom, Harel, Einav, Goldstein, Ido, Stein, Yan, Kogan-Sakin, Ira, Kamer, Iris, Solomon, Hilla, Dekel, Elya, Tal, Perry, Goldfinger, Naomi, Friedlander, Gilgi, Rotter, Varda

    Published in PloS one (22-04-2013)
    “…Mutations in the p53 tumor suppressor protein are highly frequent in tumors and often endow cells with tumorigenic capacities. We sought to examine a possible…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype by Buganim, Yosef, Goldstein, Ido, Lipson, Doron, Milyavsky, Michael, Polak-Charcon, Sylvie, Mardoukh, Corine, Solomon, Hilla, Kalo, Eyal, Madar, Shalom, Brosh, Ran, Perelman, Marina, Navon, Roy, Goldfinger, Naomi, Barshack, Iris, Yakhini, Zohar, Rotter, Varda

    Published in PloS one (11-03-2010)
    “…Partial gain of chromosome arm 17q is an abundant aberrancy in various cancer types such as lung and prostate cancer with a prominent occurrence and prognostic…”
    Get full text
    Journal Article
  9. 9

    SPATA18, a Spermatogenesis-Associated Gene, Is a Novel Transcriptional Target of p53 and p63 by Bornstein, Chamutal, Brosh, Ran, Molchadsky, Alina, Madar, Shalom, Kogan-Sakin, Ira, Goldstein, Ido, Chakravarti, Deepavali, Flores, Elsa R., Goldfinger, Naomi, Sarig, Rachel, Rotter, Varda

    Published in Molecular and Cellular Biology (01-04-2011)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10

    p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss by Brosh, Ran, Sarig, Rachel, Natan, Elad Bar, Molchadsky, Alina, Madar, Shalom, Bornstein, Chamutal, Buganim, Yosef, Shapira, Tirosh, Goldfinger, Naomi, Paus, Ralf, Rotter, Varda

    Published in FEBS letters (03-06-2010)
    “…The p53 tumor suppressor coordinates a multitude of cellular and organismal processes and exerts its activities mainly by activation of gene transcription…”
    Get full text
    Journal Article
  11. 11

    Beyond tumor suppression: p53 controls blastocyst implantation by Madar, Shalom, Goldstein, Ido, Neeman, Ortal, Rotter, Varda

    Published in Cell cycle (Georgetown, Tex.) (15-12-2011)
    “…Comment on: Sohr S, et al. Cell Cycle 2011; 10:3758-67…”
    Get full text
    Journal Article
  12. 12

    Unleash the wild type: Restoration of p53 suppressive activity in skin cancer by Madar, Shalom, Stambolsky, Perry, Rotter, Varda

    Published in Cell cycle (Georgetown, Tex.) (01-03-2011)
    “…Comment on: Bao MC, et al. Cell Cycle 2011; 10:301-307…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Inactivation of Myocardin and p16 during Malignant Transformation Contributes to a Differentiation Defect by Milyavsky, Michael, Shats, Igor, Cholostoy, Alina, Brosh, Ran, Buganim, Yosef, Weisz, Lilach, Kogan, Ira, Cohen, Merav, Shatz, Maria, Madar, Shalom, Kalo, Eyal, Goldfinger, Naomi, Yuan, Jun, Ron, Shulamit, MacKenzie, Karen, Eden, Amir, Rotter, Varda

    Published in Cancer cell (01-02-2007)
    “…Myocardin is known as an important transcriptional regulator in smooth and cardiac muscle development. Here we found that myocardin is frequently repressed…”
    Get full text
    Journal Article
  15. 15

    Mutant p53 gain of function is interwoven into the hallmarks of cancer by Solomon, Hilla, Madar, Shalom, Rotter, Varda

    Published in The Journal of pathology (01-12-2011)
    “…Cancer is viewed as being governed by several aberrant biological events defined by Weinberg and Hanahan as ‘hallmarks’. In most human cancers the tumour…”
    Get full text
    Journal Article
  16. 16

    p53, a novel regulator of lipid metabolism pathways by Goldstein, Ido, Ezra, Osnat, Rivlin, Noa, Molchadsky, Alina, Madar, Shalom, Goldfinger, Naomi, Rotter, Varda

    Published in Journal of hepatology (01-03-2012)
    “…Background & Aims In this study we aimed at characterizing the regulation of hepatic metabolic pathways by the p53 transcription factor. Methods Analysis of…”
    Get full text
    Journal Article
  17. 17

    Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53 by Goldstein, Ido, Rivlin, Noa, Shoshana, Or-yam, Ezra, Osnat, Madar, Shalom, Goldfinger, Naomi, Rotter, Varda

    Published in Carcinogenesis (New York) (01-01-2013)
    “…Cytochrome P450 (P450) enzymes are abundantly expressed in the human liver where they hydroxylate organic substrates. In a microarray screen performed in human…”
    Get full text
    Journal Article
  18. 18

    Cancer research, a field on the verge of a paradigm shift? by Goldstein, Ido, Madar, Shalom, Rotter, Varda

    Published in Trends in molecular medicine (01-06-2012)
    “…The theoretical framework for the field of cancer research is based on two main principles. The first is that cancer advances in a stepwise manner, with each…”
    Get full text
    Journal Article
  19. 19

    Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature by Solomon, Hilla, Buganim, Yosef, Kogan-Sakin, Ira, Pomeraniec, Leslie, Assia, Yael, Madar, Shalom, Goldstein, Ido, Brosh, Ran, Kalo, Eyal, Beatus, Tsevi, Goldfinger, Naomi, Rotter, Varda

    Published in Journal of cell science (01-07-2012)
    “…Concomitant expression of mutant p53 and oncogenic Ras, leading to cellular transformation, is well documented. However, the mechanisms by which the various…”
    Get full text
    Journal Article
  20. 20

    Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity by Shoshani, Ofer, Massalha, Hassan, Shani, Nir, Kagan, Sivan, Ravid, Orly, Madar, Shalom, Trakhtenbrot, Luba, Leshkowitz, Dena, Rechavi, Gideon, Zipori, Dov

    Published in Cancer research (Chicago, Ill.) (15-12-2012)
    “…Mesenchymal stromal cells (MSC) are used extensively in clinical trials; however, the possibility that MSCs have a potential for malignant transformation was…”
    Get full text
    Journal Article